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ABSTRACT 
Synthesis and Characterization of Radiopaque Shape Memory Polymer Foams 
  
Kendal Paige Ezell 
Department of Biomedical Engineering 
Texas A&M University 
 
Research Advisor: Dr. Duncan J. Maitland 
Department of Biomedical Engineering 
Texas A&M University 
 
 Shape memory polymer (SMP) foams have been proposed for a variety of medical 
applications, including brain aneurysm embolization and occlusion of peripheral vascular 
malformations. While these devices provide significant advancements in treatment, such as 
increased volumetric filling and improved healing outcomes, one inherent limitation is a lack of 
visibility under x-ray fluoroscopy. Medical professionals rely on noninvasive material 
visualization to enable safe and effective device placement. Although metal markers can assist 
with SMP device placement, it is difficult to anticipate the interactions between the expanding 
polymer device and complicated vessel anatomy. Thus, there is a significant clinical need for the 
development of SMP formulations that can be observed under x-ray during expansion. Using a 
bulk synthesis method, a contrast agent is incorporated into the polymer composition in various 
molar ratios to enhance foam visibility under x-ray. This project focuses on the synthesis and 
characterization of the radiopaque compositions necessary to achieve clinically relevant SMP 
foams. Foams are characterized in terms of radiopacity, morphology, and thermomechanical 
properties. Successful synthesis and characterization of the radiopaque foam compositions shows 
whether or not the properties are within a clinically relevant range for further device development.  
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NOMENCLATURE  
 
SMP   Shape memory polymer 
ATIPA  5-Amino-2,4,6-triiodoisophthalic acid 
BEP    2-butyl-2-ethyl-1,3-propanediol 
DEG   Diethylene glycol 
HDI   Hexamethylene diisocyanate 
Xeq   Reactive equivalents 
NCO   Isocyanate group 
Tg   Glass transition temperature 
DSC   Differential scanning calorimetry 
SEM   Scanning electron microscopy 
GDC10  Guglielmi detachable coil 
FTIR   Fourier transform infrared spectroscopy 
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CHAPTER I 
INTRODUCTION 
 
An estimated 6 million people in the United States have an unruptured cerebral aneurysm 
[1]. A cerebral aneurysm is a ballooned area of a blood vessel in the brain resulting from vessel 
wall weakening. If left untreated, these aneurysms can rupture and cause blood to flood the 
surrounding tissue. This bleeding may cause stroke, hydrocephalus, nerve damage, or even death.  
 
Current treatments for cerebral aneurysms employ Guglielmi detachable coils and 
hydrocoils as embolic agents to cut off blood flow to the aneurysm [2]. These treatments achieve 
aneurysm occlusion, but have issues with aneurysm recanalization requiring re-treatment. Shape 
memory polymer (SMP) foams have been proposed for use to optimize endovascular embolization 
of aneurysms in place of current embolization devices [3,4]. 
 
SMP foams are capable of being deformed and stored in a secondary geometry, a small 
crimped form, that enables delivery with minimally-invasive catheters. The polymers subsequently 
actuate to their expanded primary geometry in response to a stimulus, such as heating to body 
temperature [5]. The expanded foam geometry provides a better interface for aneurysm 
embolization to occur; however, treatment with these devices may be difficult due to limited 
visibility under x-ray fluoroscopy.  The SMP foams used in current devices have densities similar 
to soft tissue and therefore cannot be seen under x-ray.  
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Previous works by Hasan et al., increased x-ray visibility, or radiopacity, through the 
incorporation of tungsten nanoparticles. The resultant foams showed x-ray visibility and 
maintained thermomechanical properties; however, they also had reduced mechanical properties 
due to disruption of the SMP matrix by the nanoparticles [6].  
 
Alternatively, the incorporation of an x-ray visible agent directly into the foam composition 
could allow for a higher loading of a radiopaque agent without disrupting the matrix of SMP foam 
devices. A triodobenzene monomer has been proposed for use as a contrast agent in the foam 
composition. Specifically, 5-amino-2,4,6-triiodoisophthalic acid (ATIPA), was used because of its 
triodobenzene monomer motif and functional groups that serve as multiple foaming process 
components. Preliminary studies showed viability of the radiopaque polymer system. However, 
minimal loading of the contrast agent, decreased crosslinking, and low glass transition temperature 
were observed. To address these issues, this work focuses on optimization of the polymer system 
and characterization of the foam properties to assess clinical relevance of radiopaque foam 
compositions.  
 
The foam composition was optimized by looking at monomer composition as well as type 
and concentration of catalysts and surfactants. Further optimization was conducted by focusing on 
the foaming protocol, which is important for foam morphology. Finally, the optimized system was 
characterized in terms of radiopacity, mechanical integrity, shape memory capacity, and thermal 
transitions in relation to clinical specifications for a neurovascular embolization device.  
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CHAPTER II 
METHODS 
 
SMP Foam Synthesis  
2-butyl-2-ethyl-1,3-propanediol, (BEP, Sigma-Aldrich Inc., St. Louis, MO),  diethylene 
glycol (DEG, Sigma-Aldrich Inc., St. Louis, MO), hexamethylene diisocyanate (HDI, TCI 
America Inc., Portland, OR), 5-amino-2,4,6-triiodoisophthalic acid (ATIPA, VWR Scientific, 
Houston, TX), 5-aminoisophthalic acid (ATIPA analog, Sigma-Aldrich Inc., St. Louis, MO), 
surfactant (Air Products and Chemicals, Inc., Allentown, PA), amine catalyst (Air Products and 
Chemicals, Inc. Allentown, PA), tin catalyst (Air Products and Chemicals, Inc, Allentown, PA), 
and Enovate 245fa Blowing Agent (Honeywell International, Inc., Houston, TX) were used as 
received. 
 
The radiopaque foams were made using an equal molar ratio of AT, BEP, and DEG total 
reactive equivalents (Xeq) to total HDI isocyanate (NCO) equivalents. Figure 1 shows a schematic 
of the overall foaming process. In the initial NCO pre-polymer step, the total NCO mass was added 
to 60% of the Xeq monomers and reacted at room temp until the premix viscosity achieved 
approximately 10,000 cps. The balance of Xeq monomers was combined into a polyols mix, which 
was added to the NCO premix along with surfactant, amine catalyst, and tin catalysts at 4, 1.5, and 
0.3 wt%, respectively. The mixture was mixed at 3600 rpm using a Flacktek speed mixer 
(FlackTek, Inc., Landrum, SC) for 30 s, and subsequently mixed with 0.0625 ml/g of Enovate for 
another 20 s. The foam was immediately cured at 90 °C for 1 hr. The foams were then cooled and 
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cubed, then left to post-cure at 90 °C for 24 hr. A fourth foam composition was synthesized with 
a chemical ATIPA analog using the same method as described above.  
 
 
Figure 1. The optimized foam synthesis process wherein the pre-polymer mix is made, the 
polymer foaming occurs with the added polyols and accessory agents, and the resulting foams are 
taken through a curing cycle.  
 
Differential Scanning Calorimetry (DSC) 
The glass transition temperature (Tg) of the polymer foams was determined for the 15%, 
20%, and 25% ATIPA compositions using a Q200 DSC (TA Instruments, New Castle, DE). To 
quantify the dry Tg, a 4 mg sample was loaded into a vented aluminum pan at room temperature, 
cooled to -40 °C, and run through a heat/cool/heat cycle from -40 °C to 120 °C at temperature rates 
of 10 °C/min. Tg was determined to be the transition inflection point during the second heat cycle. 
The Tg’s were measured for an n=3 for each foam composition. 
 
Gel Fraction 
Polymer crosslinking can be quantified through gel fraction analysis. Through this method, 
each foam composition was analyzed at an n=5. The foams were massed, then subject to shaking 
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and heating at 50 °C under vacuum for 24 hours in tetrahydrofuran (Sigma-Aldrich Inc., St. Louis, 
MO). After 24 hours the remaining bulk masses of the foams were transferred to previously massed 
containers and left to dry at 50 °C under vacuum for an additional 24 hours to remove any residual 
solvent. A final mass of the dry samples was determined and used to calculate gel fraction based 
on Equation 1: 
       𝑔𝑒𝑙	  𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = ./00	  12	  34./56567	  839	  0/.:;4./00	  12	  135756/;	  0/.:;4 𝑥	  100     (Equation 1) 
 
Mechanical Testing 
The mechanical properties of the foam compositions were tested using an Insight 30 
Material Tester (MTS Systems Corporation, Eden Prairie, MN). The foams were cut and prepared 
for testing by epoxying wood tabs on each end of the samples that could be gripped by the tester. 
Each sample was subject to a constant strain rate of 5  mm/min at room temperature. Strain at break 
(%), Young's modulus (MPa), and ultimate stress (kPa) were determined for each sample using 
the stress–strain curve. An n=8 was used for the 25% ATIPA compositions; however, no data was 
able to be collected for the 15% ATIPA foam. Comparative analysis of mechanical properties was 
done using mechanical data for the 6 vol% tungsten foams as well as a control nonradiopaque SMP 
foam used currently for device development. 
 
Scanning Electron Microscopy 
Foam samples were cut into 1 mm slices in the transverse and axial planes. The sample 
slices were mounted with carbon black tape onto a stage and held under vacuum for 24 hours. The 
samples were then sputter coated with gold for 90 seconds at 20 mA using a Cressington Sputter 
Coater (Ted Pella, Inc. Redding, CA). Images of the samples were obtained using a Joel NeoScope 
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JCM-5000 Scanning Electron Microscope (SEM) (Nikon Instruments, Inc., Melviille, NY). Pore 
sizes were quantified using ImageJ (https://imagej.nih.gov/ij/), averaging the diameter of 10 foam 
cells for each image.  
 
Opacity 
Material opacity was assessed using a OEC 9800 Plus Mobile C-arm fluoroscope (GE 
Healthcare) at 62 kVp. Samples of each composition were cut into 1 cm2 pieces with thicknesses 
of 9, 3, and 1 mm. Device prototypes consisting of 2 mm diameter 25% ATIPA foam cylinders 
threaded over 200 µm nitinol wire were included on the frame in both their expanded and axially 
crimped state. Axial crimps were conducted with an SC250 heated stent crimper (Machine 
Solutions, Flagstaff, AZ) by heating the material to 70°C in the crimper bore for 15 minutes, 
radially compressing the material at 50 psi, and constraining the material as it cooled to ambient 
temperature. Samples were imaged in comparison to an industry accepted control, Guglielmi 
detachable coils (GDC10) [2]. Samples were adhered to a polypropylene sheet and imaged 
through a 0.5” aluminum plate as an analog for human skull x-ray attenuation [7]. 
 
Quantification of the radiopaque properties of the 25% ATIPA foam composition was 
done using ImageJ. A histogram of the grayscale value was taken for each sample and then 
normalized.  
 
Unconstrained Expansions 
The 25% ATIPA foam composition was cut into five cylindrical samples with 4 mm 
diameter and measuring 1 cm in length. The samples were placed onto a nitinol wire to provide 
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stability. Samples were crimped using SC250 heated stent crimper (Machine Solutions, Flagstaff, 
AZ) by heating the material to 70 °C, holding it isothermally for 15  min, and compressing the 
sample at 55 PSI as it cooled to ambient temperature. Images of the crimped foam samples were 
taken prior to expansion. For the expansions, the samples were placed in reverse osmosis water at 
37 °C for 30 minutes and imaged every 30 seconds. ImageJ was used to analyze the diameter of 
the foam samples through the expansion process.   
 
Fourier Transform Infrared Spectroscopy (FTIR) 
Thin foam samples of the 25% ATIPA and a control 25% ATIPA analog composition were 
cut (2-3 mm) for spectra analysis using Bruker ALPHA Infrared Spectrometer (Bruker, Billerica, 
MA). The samples were placed between potassium bromide discs and analyzed with a total of 32 
scans for each composition. Background spectra were determined with 20 scans of the potassium 
bromide discs. OPUS software (Bruker, Billerica, MA) was used to remove the background spectra 
from the measurements and to conduct a baseline correction for IR beam scattering. Each 
composition spectra was taken three times to confirm reproducibility. 
 
Foam Density 
Foam density for samples on the x-ray test frame were determined by obtaining foam 
volumes and masses of six different cubed samples from each composition. The volumes were 
quantified by measuring the length, width, and height in millimeters using calipers. Each sample 
was then massed, and the subsequent densities were averaged for each composition.  
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CHAPTER III 
RESULTS 
 
Foam Composition and Morphology 
 A primary goal in this project was to determine type and quantity of surfactant and catalysts 
required to obtain tunable, porous foam morphology. Based on previous work, the development of 
clinically applicable foam was pursued using BEP, DEG, HDI, and ATIPA. Various compositions 
were synthesized for scaled radiopacity, as shown in Table 1. The 25% ATIPA composition (i.e., 
25% ATIPA, 30% BEP, 45% DEG all in equivalence to 100% HDI and using a premix ratio of 
40%) provided superior fluoroscopic and chemical properties and as such was characterized 
extensively. 
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Table 1. The various compositions of foams synthesized with the molar equivalence of the polyols 
and isocyanates given, the weight percentages of surfactant and catalysts, and amount of blowing 
agent used.  
 
 
 
Through several trails, 4 wt% of surfactant yielded the most stability during the foaming 
process. Amine and urethane catalysts were used in amounts determined from previously 
established foaming protocols. Previous work has shown success and controlled reactivity using 
this set of catalysts.  
 
Determining the best pre-mix protocol for the 25% ATIPA foam composition was a major 
focus of this project. The pre-mixes were mixed at various temperatures (room temperature, 35 
°C, and 50 °C) and durations (3 hours, 6 hours, and 12 hours). Testing revealed that the room 
temperature mixing for 3 hours with a 3 hour sitting period gave the best morphology. Other 
Composition 
ATIPA 
OH 
Eq% 
BEP 
OH 
Eq% 
DEG 
OH 
Eq% 
HDI 
NCO 
Eq% 
Surfactant 
wt% 
Amine 
Catalyst 
wt% 
Urethane 
Catalyst 
wt% 
Enovate 
(mL/g) 
25% ATIPA 25 30 45 100 4 1.5 0.3 0.0625 
20% ATIPA 20 35 40 100 4 1.5 0.3 0.0625 
15% ATIPA 15 40 35 100 4 1.5 0.3 0.0625 
25%ATIPA 
Analog 25 30 45 100 4 1.5 0.3 0.0625 
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variations of the protocol caused premature oligomers to form that altered monomer solubility 
and/or gave low viscosity pre-polymer mixes that produced undesired morphologies.  
  
 The porosity of the foams was qualitatively analyzed using SEM imaging. As seen in 
Figure 2, the pore sizes increase with a decrease in ATIPA concentration.  This increase in pore 
size can be explained by taking into account the high molecular weight of the contrast agent itself. 
As described in the methods, the synthesis involves a pre-polymerization step. This step is 
important in determining the morphology of the foam-porosity. More viscous the pre-mixes results 
in reduced pore sizes, due to increased resistance to blowing. With a lower concentration of high 
molecular weight ATIPA in the pre-mix, the viscosity is decreased, resulting in increased pore 
sizes. Future work to match the pore sizes for each foam composition could be explored using 
different amounts of blowing agent and/or by altering the pre-mix ratio to include more ATIPA.  
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Figure 2. Morphologies of the foam compositions are shown above. Pore sizes are given in the 
bottom left corner of each with units of mm. Scale bar of 1 mm applies to all images. 
 
 
Radiopacity 
The major goal in the development of this SMP foam is visibility under fluoroscopy. All 
variations of the foam compositions were visible, as seen in Figure 3. However, the densities of 
the foam compositions have not been normalized; thus, we did not observe increased radiopacity 
with increased ATIPA, even though this is a known trend. The density is largely dependent on the 
foam morphology and the amount of high molecular weight contrast agent present in the foam. 
The lower percentage foams (15% and 20% ATIPA) had larger pore struts, which increased their 
densities and contributed to their seemingly greater x-ray visibility.  However, all of the samples 
can be seen at various thicknesses both with and without an aluminum plate barrier.  Relevant to 
the goal of demonstrating clinical applicability, the expanded and crimped device prototypes 
demonstrated by A and B respectively in Figure 3, were also visible. 
17 
The radiopacity of the 25% ATIPA foam was quantified by determining a normalized 
grayscale value for each thickness under the aluminum plate and for unobstructed imaging (Figure 
4). Visibility increased with increasing thickness, and only slight deterioration in visibility was 
seen following obstruction with aluminum.  
 
FTIR was performed on the 25% ATIPA foam composition along with a foam with a 25% 
ATIPA chemical analog, to demonstrate the presence of the radiopaque chemical characteristic in 
the foams (i.e. iodine). The spectra were similar to each other, as seen in Figure 5. This result 
indicates that the iodine motif of ATIPA does not greatly affect the polymer chemistry of the 
foams. However, the expected iodine peaks from incorporation of ATIPA cannot be seen. This 
result is likely because they are in the fingerprint region (~500-1500 cm-1), in which individual 
peaks are difficult to discern. Thus, the peaks attributed to other bonds within the polymer could 
be overshadowing these specific peaks. Although the FTIR spectra does not chemically confirm 
the presence of the radiopaque functionality of ATIPA, the radiopaque properties of the foam 
(Figure 3) provides confirmation of successful incorporation.  
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Figure 3. Fluoroscopy images for ATIPA foam compositions. Top left: picture of sample plate 
preparation. Top right: densities of each sample. Bottom left: Unobstructed fluoroscopy image of 
samples. Bottom right: Obstructed fluoroscopy using a half-inch aluminum plate barrier. Within 
each image, from top to bottom: 25%, 20%, and 15% ATIPA. Left to right: thicknesses of 9, 3, 
and 1 mm. Expanded: Expanded foam over wire prototype. Crimped: crimped foam over wire 
prototype. GDC10: Control Guglielmi detachable coil (GDC10).  
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Figure 4. Quantified opacification of the 25% ATIPA foam composition based on normalized 
grayscale values. Increasing opacity with sample thickness is shown, with little differentiation 
between the unobstructed images and those with the aluminum plate.  
 
 
Figure 5. FTIR spectra of the 25% ATIPA contrast agent foam (bottom) and control 25% ATIPA 
chemical analog foam (top).  
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Glass Transition Temperature/Gel Fraction 
 Thermal characterization of the foam compositions showed an increase in glass transition 
temperature with an increase in ATIPA concentration, as seen in Table 2. This trend can be 
explained by increased crosslink density that occurs with increased ATIPA. The transition 
temperatures are still very low for clinical application (at or below body temperature), since they 
affect foam actuation, which controls the amount of time that a clinician has for delivery. Previous 
foams for use in embolic applications have transition temperatures between 50 and 70 °C [4]. 
 
The gel fractions of the three foam compositions did not demonstrate any significant trends. 
The gel fractions for the highest percent of ATIPA were relatively low when compared to the 
current SMP foam formulations with gel fractions of nearly 100% [4]. While the current transition 
temperatures and gel fractions of these specific compositions are not ideal for clinical application, 
future directions include incorporating additional crosslinking agents to increase these metrics.  
 
Foam Actuation 
 Full expansion of crimped 25% ATIPA foam samples took place within 30 seconds of 
exposure to 37°C water. These results show that the foams exhibit shape memory (Figure 6). 
However, such quick response to heat is not clinically applicable, since the clinician would need 
more time for delivery through the catheter. Further investigations into increasing Tg for the foam 
need to be conducted to reduce the rate of expansion.  
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Figure 6. 25% ATIPA foam prior to crimping (left), radially crimped (middle) and after expansion 
in 37 oC water (right). Diameters given at bottom right. 
 
 
Mechanical Properties 
 Tensile testing showed that the ATIPA foams have increased modulus, strain at break, 
ultimate tensile stress, and strength relative to non-radiopaque foam formulations and radiopaque 
tungsten nanoparticle containing foams (Figure 7). High tensile strength is promising for embolic 
device applications, as it indicates a reduced risk for microtears and microfractures that would lead 
to embolic particles dislodging from the foam. When the concentration of ATIPA increased, an 
increase in modulus and ultimate stress was seen (Table 2). However, no trend for strain at break 
for the three foam compositions was observed.  
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Table 2. Quantified glass transition temperatures, gel fractions, and mechanical testing data for 
each foam composition. Mechanical properties are quantified from stress-strain curves. 
 
 
Tg (°C) 
Gel Fraction 
(%) 
Strain at 
break (%) 
Modulus 
(MPa) 
Ultimate 
stress (kPa) 
25% ATIPA 38.6±0.1 88.7±2.5 116±14 1.49±0.12 306±31 
20% ATIPA 33.5±0.3 89.3±1.0 364±7.9 0.131±0.040 215±28 
15% ATIPA 28.6±0.0 85.3±1.9 245±0 0.0851±0 94.4±0 
 
 
 
 
 
 
Figure 7. Comparison of the mechanical properties of 6 vol% tungsten nanoparticle incorporated 
foams and the 25% ATIPA contrast agent incorporated foams versus control nonradiopaque SMP 
foam currently used for device development [5]. 
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CHAPTER IV 
CONCLUSION 
 
An SMP system with a chemically incorporated triodobenzene monomer was developed 
and proven to be x-ray visible. The results showed clinically relevant morphology and pore sizes in 
the SMP foams. Additionally, these materials showed significant increases in visibility and 
toughness compared to previously reported radiopaque SMP systems. This system shows promise 
for the development of a clinically relevant device; however, further optimization is required to 
increase polymer crosslinking and glass transition temperatures to enable more clinically relevant 
medical device designs.  
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